Are Oral Dose Manufacturing Projects Becoming More Complicated?
Source: ISR Reports
By Kate Hammeke, VP of Market Research, Industry Standard Research (ISR) @ISRreports

For the past six years, Industry Standard Research has asked oral dose outsourcers about the proportions of their projects that are simple, neither simple nor complex, and complex. Considering the formulation challenges and solubility issues that can come with more complex molecules, I anticipated there would be an uptick in the proportions of complex oral dose projects over time. Data from ISR’s research on oral dose manufacturing suggests my hypothesis was wrong. At least for now.
VIEW THE ARTICLE!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Outsourced Pharma? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
ISR Reports
This website uses cookies to ensure you get the best experience on our website. Learn more